Development of Subretinal Fibrosis After Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration

被引：75

作者：

Hwang, John C. ^{[1
]}

Del Priore, Lucian V. ^{[1
,2
]}

Freund, K. Bailey ^{[2
]}

Chang, Stanley ^{[1
]}

Iranmanesh, Reza ^{[1
]}

机构：

[1] Columbia Univ, Med Ctr, Edward S Harkness Eye Inst, New York, NY 10032 USA

[2] Retina Macula Consultants New York, New York, NY USA

来源：

OPHTHALMIC SURGERY LASERS & IMAGING | 2011年 / 42卷 / 01期

关键词：

TISSUE GROWTH-FACTOR; CHOROIDAL NEOVASCULARIZATION;

D O I：

10.3928/15428877-20100924-01

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

BACKGROUND AND OBJECTIVE: To describe the development or progression of subfoveal fibrosis after anti-vascular endothelial growth factor (VEGF) therapy in the absence of significant subfoveal hemorrhage in neovascular age-related macular degeneration. PATIENTS AND METHODS: Retrospective case series. RESULTS: Seven eyes of seven patients with neovascular age-related macular degeneration developed subfoveal fibrosis after anti-VEGF therapy in the absence of significant subfoveal hemorrhage. Five of seven patients experienced vision loss of 0.3 logarithm of the minimum angle of resolution units or greater. CONCLUSION: Subfoveal fibrosis may develop or progress in neovascular age-related macular degeneration despite the absence of significant subfoveal hemorrhage and treatment with anti-VEGF. Development of anti-fibrotic therapeutics may be beneficial in reducing the incidence of subretinal fibrosis.

引用

页码：6 / 11

页数：6

共 9 条

[1] Evolving guidelines for intravitreous injections
Aiello, LP
Brucker, AJ
Chang, S
Cunningham, ET
D'Amico, DJ
Flynn, HW
Grillone, LR
Hutcherson, S
Liebmann, JM
O'Brien, TP
Scott, IU
Spaide, RF
Ta, C
[J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2004, 24 (05): : S3 - S19
[2] Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900
[3] Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
[4] A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization
He, S
Jin, ML
Worpel, V
Hinton, DR
[J]. ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (09) : 1283 - 1288
[5] The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
Kuiper, Esther J.
Van Nieuwenhoven, Frans A.
de Smet, Marc D.
van Meurs, Jan C.
Tanck, Michael W.
Oliver, Noelynn
Klaassen, Ingeborg
Van Noorden, Cornelis J. F.
Goldschmeding, Roel
Schlingemann, Reinier O.
[J]. PLOS ONE, 2008, 3 (07):
[6] Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844
[7] Short-term safety and efficacy of intravitreal bevacizumab (avastin) for neovascular agerelated macular degeneration
Rich, Ryan M.
Rosenfeld, Philip J.
Puliafito, Carmen A.
Dubovy, Sander R.
Davis, Janet L.
Flynn, Harry W., Jr.
Gonzalez, Serafin
Feuer, William J.
Lin, Richard C.
Lalwani, Geeta A.
Nguyen, Jackie K.
Kumar, Gaurav
[J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (05): : 495 - 511
[8] Ranibizumab for neovascular age-related macular degeneration
Rosenfeld, Philip J.
Brown, David M.
Heier, Jeffrey S.
Boyer, David S.
Kaiser, Peter K.
Chung, Carol Y.
Kim, Robert Y.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) : 1419 - 1431
[9] Expression of connective tissue growth factor and its potential role in choroidal neovascularization
Watanabe, D
Takagi, H
Suzuma, K
Oh, H
Ohashi, H
Honda, Y
[J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (07): : 911 - 918

← 1 →